Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Client Understanding, Expectations, and Intern Performance in Occupational Therapy

NCT07333794 · tracked via the Priya Life Science Taiwan tracker
Phase
Observational
Started
2026-02-01
Last updated
2026-01-12

Condition(s) studied

Communication

Investigational drug(s) / intervention(s)

Clinical Interview and Occupational Therapy Knowledge (OTK) Health Education Session

Clinical Interview and Occupational Therapy Knowledge (OTK) Health Education Session: This study involves observational procedures, including: (1) a health education session on occupational therapy knowledge (OTK) delivered by occupational therapy interns, and (2) a semi-structured chief complaint and expectation interview conducted with psychiatric clients by interns. Clinical supervisors and external experts evaluate interns' performance using standardized rating scales, which are developed in this study. No therapeutic or experimental interventions are provided to participants.

Study summary

This study aims to investigate psychiatric clients' understanding of occupational therapy (OT), the reasonableness of their expectations regarding OT services, and OT interns' performance in Occupational Therapy Knowledge (OTK) health education and chief complaint/expectation interviews. The project includes developing assessment instruments for client OT knowledge, expectation reasonableness, and intern communication/education performance, followed by data collection in real clinical settings. Clients, clinical supervisors, and external experts will contribute ratings to evaluate instrument validity and reliability. The study will provide foundational evidence for improving OT health education, communication training, and clinical teaching practices.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Occupational Therapy Students: Currently completing a clinical internship in psychiatric occupational therapy. 2. Clinical Supervisors: Willing to participate in the study. 3. Psychiatric Clients: (1) Age 20 years or older. (2) Diagnosed with a psychiatric disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. (3) Able to understand simple questions and follow three-step commands. Exclusion Criteria: 1. Occupational Therapy Students: Unwilling to be audio-recorded. 2. Clinical Supervisors: No exclusion criteria. 3. Psychiatric Clients: Unwilling to be audio-recorded.

Primary outcome measure(s)

  • Occupational Therapy Knowledge Score — Baseline
    Clients' level of understanding of occupational therapy, measured using the Occupational Therapy Knowledge Assessment, which will be developed in this study. Higher scores will indicate greater knowledge of occupational therapy. The score range is not yet finalized.
  • Occupational Therapy Expectation Reasonableness Score — Baseline
    Clients' expectations regarding occupational therapy processes and outcomes will be evaluated using the Occupational Therapy Expectation Reasonableness Scale, which will be developed in this study. Higher scores will indicate more clinically appropriate expectations. The score range is not yet finalized.
  • Occupational Therapy Knowledge Health Education Performance Score — Baseline
    Occupational Therapy interns' performance in delivering occupational therapy health education to psychiatric clients will be evaluated using the Occupational Therapy Knowledge Health Education Performance Scale, which will be developed in this study. Higher scores will indicate better performance in delivering health education. The score range is not yet finalized.
  • Chief Complaint/Expectation Interview Performance Score — Baseline
    Occupational Therapy interns' performance in conducting chief complaint and expectation interviews will be evaluated using the Interview Performance Scale, which will be developed in this study. Higher scores will indicate better interview performance. The score range is not yet finalized.

Trial sites (1)

FacilityCityRegionStatus
Chang Gung Medical Hospital Kaohsiung City Niaosong Dist
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07333794 on ClinicalTrials.gov ↗ ← All trials in Taiwan